Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H N van Schaik

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Pharmacogenetics in daily practice]T van Gelder, R H N van Schaik
The Netherlands Journal of Medicine|May 17, 2006
Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphismsA van der Padt, R H N van Schaik, P Sonneveld
Dermatology (Basel, Switzerland)|December 28, 2006
C-kit Asp-816-Val mutation analysis in patients with mastocytosisA Verzijl, R Heide, A P Oranje, et al.
The Netherlands Journal of Medicine|May 29, 2013
A clinical approach to pharmacogeneticsL C G de Graaff, R H N van Schaik, T van Gelder
Clinical Chemistry|October 18, 2008
Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detectionF H Jansen, M Roobol, C H Bangma, et al.
Tijdschrift Voor Psychiatrie|January 8, 2020
[Too early for pharmacogenetics in psychiatric practice? Implementation is in full swing]R van Westrhenen, P M Bet, M van Weelden, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 28, 2014
CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureasG Ragia, A Tavridou, L Elens, et al.
Clinical Pharmacology and Therapeutics|December 13, 2012
Doubt about the feasibility of preemptive genotypingB C P Koch, R H N van Schaik, T van Gelder, et al.
The Pharmacogenomics Journal|April 22, 2009
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitusM L Becker, L E Visser, R H N van Schaik, et al.
Clinical Pharmacology and Therapeutics|June 29, 2007
Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitusM L Becker, L E Visser, P H Trienekens, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Pharmacogenetics in daily practice]T van Gelder, R H N van Schaik
The Netherlands Journal of Medicine|May 17, 2006
Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphismsA van der Padt, R H N van Schaik, P Sonneveld
Dermatology (Basel, Switzerland)|December 28, 2006
C-kit Asp-816-Val mutation analysis in patients with mastocytosisA Verzijl, R Heide, A P Oranje, et al.
The Netherlands Journal of Medicine|May 29, 2013
A clinical approach to pharmacogeneticsL C G de Graaff, R H N van Schaik, T van Gelder
Clinical Chemistry|October 18, 2008
Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detectionF H Jansen, M Roobol, C H Bangma, et al.
Tijdschrift Voor Psychiatrie|January 8, 2020
[Too early for pharmacogenetics in psychiatric practice? Implementation is in full swing]R van Westrhenen, P M Bet, M van Weelden, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 28, 2014
CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureasG Ragia, A Tavridou, L Elens, et al.
Clinical Pharmacology and Therapeutics|December 13, 2012
Doubt about the feasibility of preemptive genotypingB C P Koch, R H N van Schaik, T van Gelder, et al.
The Pharmacogenomics Journal|April 22, 2009
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitusM L Becker, L E Visser, R H N van Schaik, et al.
Clinical Pharmacology and Therapeutics|June 29, 2007
Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitusM L Becker, L E Visser, P H Trienekens, et al.
Pageof 5